Literature DB >> 34718910

Transthyretin and retinol-binding protein as discriminators of diabetic retinopathy in type 1 diabetes mellitus.

Weixia Sun1,2,3, Yingzhou Shi1,2,3, Jiaxuan Yang1,2,3, Xiaojun Song1,2,3, Yajuan Zhang1,2,3, Wendi Zhang1,2,3, Xinli Zhou4,5,6.   

Abstract

PURPOSE: Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus (DM), which is still a major reason for blindness. Transthyretin (TTR) and retinol-binding protein (RBP) are thought to be related to the pathogenesis both in T2DM and T1DM. We aimed to investigate the association between serum levels of TTR, RBP, RBP/TTR ratio, and DR.
METHODS: This retrospective study involved 188 T1DM inpatients divided into two groups: patients with DR (n = 95) and patients without DR (n = 93). Data of serum levels on lipids and inflammation were collected. Multiple logistic regression analysis was performed to research the association between TTR, RBP, RBP/TTR, and diabetic retinopathy in T1DM.
RESULTS: Compared with patients without DR, those with DR have a higher level of TTR (207 versus 195 mg/L, p = 0.034) and RBP4 (36.85 versus 25.68 mg/L, p < 0.001). Significant differences were also observed between two groups with respect to body mass index (BMI), blood pressure (BP), total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), homocysteine, apolipoprotein B (APOB), leucocyte, monocyte, neutrophil, and uric acid (p < 0.05 for all). TTR, RBP, and RBP/TTR were positively correlated with BP, BMI, TG, LDL, homocysteine, APOB, and uric acid. A multivariate logistic regression model revealed individuals with RBP4 level in the highest quartile had 58.95 times higher risk of developing diabetic retinopathy than those in the lowest quartile.
CONCLUSIONS: In conclusion, TTR, RBP, and RBP/TTR ratio are risk factors of DR in T1DM. They are potential markers and targets for diagnosis and treatment of DR.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Diabetic retinopathy; Inflammation; Retinol-binding protein; Transthyretin

Mesh:

Substances:

Year:  2021        PMID: 34718910     DOI: 10.1007/s10792-021-02088-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

1.  Transthyretin (prealbumin) in the pancreas and sera of newly diagnosed type I (insulin-dependent) diabetic patients.

Authors:  N Itoh; T Hanafusa; J Miyagawa; S Tamura; M Inada; S Kawata; N Kono; S Tarui
Journal:  J Clin Endocrinol Metab       Date:  1992-06       Impact factor: 5.958

2.  Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice.

Authors:  Yi Tan; Lun-Quan Sun; Mohammad A Kamal; Xiaoyang Wang; J Paul Seale; Xianqin Qu
Journal:  Biochim Biophys Acta       Date:  2011-10-01

3.  Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.

Authors:  S Schröder; W Palinski; G W Schmid-Schönbein
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

4.  Transthyretin represses neovascularization in diabetic retinopathy.

Authors:  Jun Shao; Yong Yao
Journal:  Mol Vis       Date:  2016-10-12       Impact factor: 2.367

5.  Low Serum Levels of Prealbumin, Retinol Binding Protein, and Retinol Are Frequent in Adult Type 1 Diabetic Patients.

Authors:  Luis Forga; Federico Bolado; María José Goñi; Ibai Tamayo; Berta Ibáñez; Carlos Prieto
Journal:  J Diabetes Res       Date:  2016-11-29       Impact factor: 4.011

6.  Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4.

Authors:  Mei Du; Ashley Martin; Franklin Hays; Jennifer Johnson; Rafal A Farjo; Krysten M Farjo
Journal:  Mol Vis       Date:  2017-03-31       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.